Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
04 Injection-site reaction Mild redness or swelling at the injection site is the most commonly reported AOD-9604 adverse event in trials
%20(1).png)
This clean safety profile contributed to the FDA granting GRAS (Generally Recognized As Safe) status for AOD-9604 as a food ingredient in 2007
Triny will choose the right form for you based on your goals and your history
The peptide displays a favorable safety profile in preclinical settings with minimal irritation
US$ 21.42
US$ 28.51
US$ 21.38
US$ 23.39
US$ 29.62
US$ 24.28
